Bausch Health
BHC
#3687
Rank
C$4.06 B
Marketcap
$11.00
Share price
0.39%
Change (1 day)
11.51%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : C$30.79 Billion

According to Bausch Health 's latest financial reports the company's total debt is C$30.79 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 2023 to 2023)

Total debt by year

Year Total debt Change
2023-12-31C$29.69 B5.38%
2022-12-31C$28.17 B-2.4%
2021-12-31C$28.87 B-5.36%
2020-12-31C$30.50 B-9.8%
2019-12-31C$33.82 B2.15%
2018-12-31C$33.10 B3.5%
2017-12-31C$31.98 B-20.24%
2016-12-31C$40.10 B-7.04%
2015-12-31C$43.14 B144.05%
2014-12-31C$17.68 B-4.44%
2013-12-31C$18.50 B68.73%
2012-12-31C$10.96 B62.07%
2011-12-31C$6.76 B83.35%
2010-12-31C$3.68 B793.95%
2009-12-31C$0.41 B432.92%
2008-12-31C$77.45 M
2006-12-31C$0.47 B-6.02%
2005-12-31C$0.50 B-11.58%
2004-12-31C$0.57 B-45.42%
2003-12-31C$1.05 B-10.7%
2002-12-31C$1.18 B1505.13%
2001-12-31C$73.53 M-93.36%
2000-12-31C$1.10 B458.07%
1999-12-31C$0.19 B1.65%
1998-12-31C$0.19 B2686.82%
1997-12-31C$7 M-26.98%
1996-12-31C$9.58 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.73 B-97.62%๐Ÿ‡บ๐Ÿ‡ธ USA